Vulnerability in Baxter Sigma Spectrum Infusion System

CVE-2020-12045

The Baxter Spectrum WBM (v17, v20D29, v20D30, v20D31, and v22D24) when used in conjunction with a Baxter Spectrum v8.x (model 35700BAX2), operates a Telnet service on Port 1023 with hard-coded credentials.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.017 (75.9th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 76th percentile — 75.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2020-12045: held from 0.017 to 0.017.

EPSS over last 30 days · oldest: 0.017 · newest: 0.017 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2020-12045?
CVE-2020-12045 is a critical-severity vulnerability in Baxter Sigma Spectrum Infusion System, classified under Use of Hard-coded Password. CVSS score: 9.8/10. Published 2020-06-29.
How severe is CVE-2020-12045?
Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2020-12045 known to be exploited?
2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.